Background: Significant myocardial scar in the posterolateral left ventricle (LV) has been associated with a diminished response to cardiac resynchronization therapy (CRT) in patients with coronary artery disease, but the effects of resting perfusion abnormalities in nonischemic cardiomyopathy (NICM) are yet to be described. Hypothesis: We sought to characterize the effect of myocardial perfusion abnormalities upon echocardiographic outcomes of CRT in patients with NICM. Methods: Twenty-one patients (mean age 64.4 ± 13.3; 71.4% male; mean left ventricular ejection fraction [LVEF] 20.2 ± 6.9%) with NICM who underwent CRT implantation and Thallium-201 single positron emission computed tomography (SPECT) myocardial perfusion imaging (MPI) were included. MPI studies were read quantitatively, assigning each of 17 myocardial segments a perfusion score (0-4) and cumulatively generating a summed perfusion score (SPS). The LV lead position was determined by chest radiography. Echocardiograms were performed both before and after (median 12 mo) CRT in 15 patients. Results: Echocardiographic response, defined as ≥15% relative increase in LVEF, was documented in 8 (53.3%) of 15 patients. All patients (5/5) with an SP ≤6 responded to CRT, whereas only 30.0% (3/10) with an SPS >6 responded (odds ratio 3.33 [95% confidence interval {CI} 1.29-8.59]; p = 0.01). All nonresponders had inferior perfusion defects. Defect density adjacent to the LV lead tip had little demonstrable effect upon CRT efficacy. Conclusions: The presence of significant myocardial perfusion defects negatively influences echocardiographic response to CRT in NICM. These findings warrant prospective confirmation and histopathological correlation with explanted hearts. © 2008 Wiley Periodicals, Inc.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Adelstein, E. C., & Saba, S. (2008). Baseline scintigraphic abnormalities by myocardial perfusion imaging predict echocardiographic response to cardiac resynchronization therapy in nonischemic cardiomyopathy. Clinical Cardiology, 31(5), 217–224. https://doi.org/10.1002/clc.20116